Capital Management Lp Lynx1

Current Holdings

Tscan Therapeutics, Inc. (TCRX)
10% or greater ownership
Security Holdings
Common Stock 5,224,600 shares
Common stock, $0.0001 par value per share Common Stock 5,240,000 shares

Cumulative Trading

Graph Options

Select a company

Select stock types

This page tracks insider trading for Capital Management Lp Lynx1, which means you can track and be informed when insider trading (i.e., insider trades) occurs. Trading stock is common amongst insiders, and the SEC requires stock trades (such as when individuals buy stock, sell stock, receive stock compensation, etc.) from insiders to be made publicly available. Some people follow the insider market to help them when investing in the stock market (e.g., when deciding whether to buy stocks). On this page, you will see stock trading that Capital Management Lp Lynx1 has engaged in since 2023. As shown above, Capital Management Lp Lynx1 has completed -$63,952 in total transactions, which were made available through the SEC Form 4, a regulatory filing that makes stock exchange data like this public knowledge.

Found 1 filings

Positive values indicate buys, negative values indicate sales.

Ticker Date Net Cash Net Shares Bought Cash Bought Shares Sold Cash Sold Shares
TCRX 2023-5-31 -$63,952 -25,400 $0 0 -$63,952 -25,400 SEC Filing

The data shown here is based on historical filings with the SEC, and may contain slight inaccuracies.

This data excludes derivative holdings and transactions.

Additional data regarding trading activity for Capital Management Lp Lynx1 before the earliest date displayed on this page may exist, but is not shown here.